These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 1805700)

  • 21. Antibacterial and antimycobacterial treatment for inflammatory bowel disease.
    Ohkusa T; Sato N
    J Gastroenterol Hepatol; 2005 Mar; 20(3):340-51. PubMed ID: 15740475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antimicrobial activities of novel 1H-dibenzo[a,c]carbazoles from dehydroabietic acid.
    Gu W; Wang S
    Eur J Med Chem; 2010 Oct; 45(10):4692-6. PubMed ID: 20702006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New antimicrobial drugs: an update].
    Burgmann H
    Wien Med Wochenschr; 2003; 153(7-8):166-8. PubMed ID: 12764871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic infections.
    Golkar FC; Rosemurgy AS
    Arch Surg; 2011 May; 146(5):619. PubMed ID: 21739658
    [No Abstract]   [Full Text] [Related]  

  • 25. Symposium on antimicrobial agents.
    Hermans PE
    Mayo Clin Proc; 1983 Jan; 58(1):3-5. PubMed ID: 6823151
    [No Abstract]   [Full Text] [Related]  

  • 26. Metal based new triazoles: their synthesis, characterization and antibacterial/antifungal activities.
    Sumrra SH; Chohan ZH
    Spectrochim Acta A Mol Biomol Spectrosc; 2012 Dec; 98():53-61. PubMed ID: 22982389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and biosynthesis of xenoamicins from entomopathogenic Xenorhabdus.
    Zhou Q; Grundmann F; Kaiser M; Schiell M; Gaudriault S; Batzer A; Kurz M; Bode HB
    Chemistry; 2013 Dec; 19(49):16772-9. PubMed ID: 24203528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
    Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
    Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in antimicrobial resistance and outcomes of health care-associated infections.
    Aydın M; Azak E; Bilgin H; Menekse S; Asan A; Mert HTE; Yulugkural Z; Altunal LN; Hatipoğlu ÇA; Tuncer Ertem G; Altunok ES; Demirkaya MH; Çeviker SA; Akgul F; Memis Z; Konya P; Azap A; Aydin G; Korkmaz D; Karakoç ZÇ; Yapar D; Karakecili F; Gunal O; Keske S; Kapmaz M; Kader C; Demirel A; Ergönül Ö
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1737-1742. PubMed ID: 33586014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular biology aspects of the antimicrobial effect of chemotherapeutic agents--antibiotics].
    Popov N
    Z Arztl Fortbild (Jena); 1982 Jul; 76(14):624-33. PubMed ID: 7180029
    [No Abstract]   [Full Text] [Related]  

  • 31. Iseganan. IB 367, protegrin IB 367.
    Drugs R D; 2002; 3(1):52-5. PubMed ID: 11881532
    [No Abstract]   [Full Text] [Related]  

  • 32. New macrolide, lincosaminide and streptogramin B antibiotics.
    Kirst HA
    Expert Opin Ther Pat; 2010 Oct; 20(10):1343-57. PubMed ID: 20645886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
    Hiddemann W; Maschmeyer G; Runde V; Einsele H
    Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antimicrobial resistance].
    Salzberger B; Welte T
    Internist (Berl); 2015 Nov; 56(11):1231-2. PubMed ID: 26507817
    [No Abstract]   [Full Text] [Related]  

  • 35. Antimicrobial activities of selected Cyathus species.
    Liu YJ; Zhang KQ
    Mycopathologia; 2004 Feb; 157(2):185-9. PubMed ID: 15119855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new problem: multiresistant fungi].
    Wehr A
    Dtsch Med Wochenschr; 1997 Mar; 122(11):A9. PubMed ID: 9102278
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, antimicrobial, and mosquito larvicidal activity of 1-aryl-4-methyl-3,6-bis-(5-methylisoxazol-3-yl)-2-thioxo-2,3,6,10b-tetrahydro-1H-pyrimido[5,4-c]quinolin-5-ones.
    Rajanarendar E; Reddy MN; Murthy KR; Reddy KG; Raju S; Srinivas M; Praveen B; Rao MS
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6052-5. PubMed ID: 20813527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marine Macrolides with Antibacterial and/or Antifungal Activity.
    Karpiński TM
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31018512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.